xmlns:atom="http://www.w3.org/2005/Atom"
5. Unless paragraphs 6 to 10 apply, the fee payable under regulation 33(3) in connection with the holding of a marketing authorization relating to a medicinal product of a kind described in column 1 of the following table is the applicable fee specified in the corresponding entry in column 2 of that table.
Column 1 Type of Medicinal Product | Column 2 Fee payable | |||
---|---|---|---|---|
1. New Active Substance | £23,025 | |||
2. Parallel Import | £300 | |||
3. Others | ||||
(a) | Any product (not being a derivative of a new active substance) in respect of which a marketing authorization has been granted in consequence of a complex application submitted on or after 1st April 1989 | £9,481 | ||
(b) | Prescription Only Medicine | |||
(i) | Standard Fee | £2,371 | ||
(ii) | Reduced Rate Fee | £1,183 | ||
(iii) | Lower Fee | £300 | ||
(c) | Pharmacy | £300 | ||
(d) | General Sale List | £300 | ||
(e) | Herbal remedy | £75 | ||
(f) | Traditional herbal registrations | £75 | ||
(g) | National homoeopathic product | £75 | ||
(h) | Homoeopathic or anthroposophic product which is the subject of a licence of right | £75 |